pre-miRNA Information
pre-miRNA hsa-mir-3128   
Genomic Coordinates chr2: 177255945 - 177256010
Description Homo sapiens miR-3128 stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA hsa-miR-3128
Sequence 5| UCUGGCAAGUAAAAAACUCUCAU |27
Evidence Experimental
Experiments Illumina
DRVs in miRNA
Mutant ID Mutant Position Mutant Source
COSN31530001 21 COSMIC
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1235581387 2 dbSNP
rs1336086844 4 dbSNP
rs1049299498 14 dbSNP
rs1442692120 17 dbSNP
rs574224659 17 dbSNP
rs911997793 17 dbSNP
rs1235274433 19 dbSNP
rs868602383 21 dbSNP
Putative Targets

Gene Information
Gene Symbol ZDHHC6   
Synonyms DHHC-6, ZNF376
Description zinc finger DHHC-type containing 6
Transcript NM_022494   
Expression
Putative miRNA Targets on ZDHHC6
3'UTR of ZDHHC6
(miRNA target sites are highlighted)
>ZDHHC6|NM_022494|3'UTR
   1 CTGCTGTTAAAACAAAATTATCCTTTAAGTCTGCTTAATTACTTGAAAATTGTACATATTACTAAAGAATTATGCAATGA
  81 GCCTACTCTGGTTAAGATGTTCTTTTCCTCAAAGGTGCCCTAGTGCCATGATTTAAATATTTTTATTACCATTTTGAAAT
 161 GGAGAAGCCATTCTGCATATGCCTTTGAATTCCTGCCCCTCTTTACCACCTCTTCCTCCCCCTCAAAGGAAAAACATTTC
 241 ATCCAAGTAAGTTAACGGCATTTTCTGTAGGATTTTCTTATGCACTGCACACTCTGGACCTCACCTGCAGATACAGTTCC
 321 CCCCTTGCCAGGAGCATCTGCATGTGGTACTTCTCTTTTCCCTCAGTTGATATTTCTTATATGATATTCTAGATACTATA
 401 GAACTCAATTTGTCAGATTCAGTATAACCTCAGATTTTGTTACCTGTCTTTTAAAAATGCAGATTTTGTCAAATCAAATA
 481 AAGATCAATGGATGTTGGGTATAATCAGTTTTTAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' uacUCUCAAAAAAUGAACGGUCu 5'
             | ||||     |||||||| 
Target 5' gatACAGTTCCCCCCTTGCCAGg 3'
310 - 332 152.00 -14.60
2
miRNA  3' uacUCUCAAAAAAUGAACGGUCu 5'
             | ||   |  |:|||:||| 
Target 5' actATAGAACTCAATTTGTCAGa 3'
395 - 417 132.00 -11.00
3
miRNA  3' uacUCU-CAA-AAAA------UGAACGGucu 5'
             ||| ||| ||||      |  ||||   
Target 5' ttaAGATGTTCTTTTCCTCAAAGGTGCCcta 3'
92 - 122 86.00 -5.22
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN31598833 4 COSMIC
COSN27005628 34 COSMIC
COSN18713442 67 COSMIC
COSN31483780 88 COSMIC
COSN31492251 91 COSMIC
COSN30516638 99 COSMIC
COSN31610282 116 COSMIC
COSN30171337 121 COSMIC
COSN20077035 126 COSMIC
COSN15145345 164 COSMIC
COSN28700388 210 COSMIC
COSN31531999 257 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1300106949 1 dbSNP
rs766989139 1 dbSNP
rs1232246837 5 dbSNP
rs375107079 6 dbSNP
rs1452903816 15 dbSNP
rs1399238769 18 dbSNP
rs776962443 20 dbSNP
rs1212737231 23 dbSNP
rs568620484 26 dbSNP
rs948134506 27 dbSNP
rs747279719 29 dbSNP
rs777487530 33 dbSNP
rs1371794686 37 dbSNP
rs1279553660 46 dbSNP
rs367647882 56 dbSNP
rs1265917689 60 dbSNP
rs916622942 61 dbSNP
rs1056832176 69 dbSNP
rs773144559 71 dbSNP
rs1017966870 73 dbSNP
rs1416207712 80 dbSNP
rs1006630646 90 dbSNP
rs889282886 91 dbSNP
rs1451570311 92 dbSNP
rs1197423649 97 dbSNP
rs562459473 98 dbSNP
rs1043863234 100 dbSNP
rs1157668029 112 dbSNP
rs1248505964 115 dbSNP
rs946885255 120 dbSNP
rs892692416 125 dbSNP
rs1410044586 140 dbSNP
rs1410755629 145 dbSNP
rs375307258 149 dbSNP
rs1052708420 150 dbSNP
rs1389873504 162 dbSNP
rs939318309 164 dbSNP
rs769957832 168 dbSNP
rs1325495765 182 dbSNP
rs908099839 198 dbSNP
rs1408759804 201 dbSNP
rs183302243 209 dbSNP
rs2290965 210 dbSNP
rs1487422129 218 dbSNP
rs909962992 222 dbSNP
rs1292726516 225 dbSNP
rs1490516265 226 dbSNP
rs1216504127 234 dbSNP
rs983940914 245 dbSNP
rs1249834816 246 dbSNP
rs146904721 251 dbSNP
rs536622171 256 dbSNP
rs1231352556 257 dbSNP
rs2290964 270 dbSNP
rs2290963 271 dbSNP
rs1017942642 275 dbSNP
rs1428474920 280 dbSNP
rs529247233 280 dbSNP
rs1234765344 291 dbSNP
rs976667284 293 dbSNP
rs1305663394 304 dbSNP
rs1008286063 314 dbSNP
rs1287818655 317 dbSNP
rs1311638911 319 dbSNP
rs965007956 322 dbSNP
rs1017937160 323 dbSNP
rs1243079031 325 dbSNP
rs955305809 326 dbSNP
rs1360823545 327 dbSNP
rs1430764290 338 dbSNP
rs1346432511 339 dbSNP
rs1227712851 343 dbSNP
rs1006971989 348 dbSNP
rs1484104321 350 dbSNP
rs999382461 360 dbSNP
rs968465806 370 dbSNP
rs1440413870 373 dbSNP
rs1189379169 380 dbSNP
rs1322191694 387 dbSNP
rs1448823328 388 dbSNP
rs1166698141 395 dbSNP
rs1391471551 398 dbSNP
rs1021808374 402 dbSNP
rs1043945422 405 dbSNP
rs765302733 407 dbSNP
rs1399631951 422 dbSNP
rs1419107643 425 dbSNP
rs1167476744 428 dbSNP
rs1012338090 443 dbSNP
rs1228280121 449 dbSNP
rs369410198 450 dbSNP
rs576513496 450 dbSNP
rs1419024066 472 dbSNP
rs1187208063 476 dbSNP
rs1228250927 480 dbSNP
rs892653730 484 dbSNP
rs1486915673 487 dbSNP
rs1056485356 495 dbSNP
rs939303723 499 dbSNP
rs3180431 502 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions TZM-bl
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL ...

- Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio.

Article - Whisnant AW; Bogerd HP; Flores O; Ho P; et al.
- mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
CLIP-seq Support 1 for dataset GSM4903833
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / CTL_TD_21_a
Location of target site NM_022494 | 3UTR | ACUGCACACUCUGGACCUCACCUGCAGAUACAGUUCCCCCCUUGCCAGGAGCAUCUGCAUGUGGUACUUCUCUUUUCCCUCAGUUGAUAUUUCUUAUAUGAUAUUCUAGAUACUAUAGAACUCAAU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset GSM4903835
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / CTL_TD_21_c
Location of target site NM_022494 | 3UTR | GUUCCCCCCUUGCCAGGAGCAUCUGCAUGUGGUACUUCUCUUUUCCCUCAGUUGAUAUUUCUUAUAUGAUAUUCUAGAUACUAUAGAACUCAAU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 3 for dataset GSM4903836
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / 124_TD_21_a
Location of target site NM_022494 | 3UTR | AUGCACUGCACACUCUGGACCUCACCUGCAGAUACAGUUCCCCCCUUGCCAGGAGCAUCUGCAUGUGGUACUUCUCUUUUCCCUCAGUUGAUAUUUCUUAUAUGAUAUUCUAGAUACUAUAGAACUCAAU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 4 for dataset GSM4903837
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / 124_TD_21_b
Location of target site NM_022494 | 3UTR | UUAUGCACUGCACACUCUGGACCUCACCUGCAGAUACAGUUCCCCCCUUGCCAGGAGCAUCUGCAUGUGGUACUUCUCUUUUCCCUCAGUUGAUAUUUCUUAUAUGAUAUUCUAGAUACUAUAGAACUCAAU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 5 for dataset GSM4903838
Method / RBP HITS-CLIP / AGO
Cell line / Condition Dermal fibroblasts / 124_TD_21_c
Location of target site NM_022494 | 3UTR | AUGCACUGCACACUCUGGACCUCACCUGCAGAUACAGUUCCCCCCUUGCCAGGAGCAUCUGCAUGUGGUACUUCUCUUUUCCCUCAGUUGAUAUUUCUUAUAUGAUAUUCUAGAUACUAUAGAACUCAAU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Accession Series GSE161239
CLIP-seq Viewer Link
CLIP-seq Support 6 for dataset GSM1462574
Method / RBP PAR-CLIP / AGO2
Cell line / Condition TZM-bl / TZM-bl ami BaL
Location of target site ENST00000369405.3 | 3UTR | CAUUUUCUGUAGGAUUUUCUUAUGCACUGCACACUCUGGACCUCACCUGCAGAUACAGUUCCCCCCUUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23592263 / GSE59944
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
Click to see details
Click to see details
Click to see details
Click to see details
57 hsa-miR-3128 Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT080091 C18ORF25 chromosome 18 open reading frame 25 2 6
MIRT109617 KLHL15 kelch like family member 15 2 6
MIRT122644 E2F3 E2F transcription factor 3 2 2
MIRT204532 SLC39A10 solute carrier family 39 member 10 2 2
MIRT221677 ZNRF2 zinc and ring finger 2 2 2
MIRT230763 PAFAH1B2 platelet activating factor acetylhydrolase 1b catalytic subunit 2 2 6
MIRT273299 CCNT1 cyclin T1 2 2
MIRT283494 KCTD5 potassium channel tetramerization domain containing 5 2 4
MIRT296656 MRGBP MRG domain binding protein 2 6
MIRT301972 NUP50 nucleoporin 50 2 4
MIRT332732 QSER1 glutamine and serine rich 1 2 2
MIRT456187 ZDHHC6 zinc finger DHHC-type containing 6 2 2
MIRT460334 CAMK4 calcium/calmodulin dependent protein kinase IV 2 6
MIRT478382 DDAH1 dimethylarginine dimethylaminohydrolase 1 2 2
MIRT508130 AMD1 adenosylmethionine decarboxylase 1 2 2
MIRT511876 GOLGA7 golgin A7 2 6
MIRT512926 UBL4A ubiquitin like 4A 2 2
MIRT515891 FAM182B family with sequence similarity 182 member B 2 2
MIRT516564 PARP1 poly(ADP-ribose) polymerase 1 2 4
MIRT520203 WASL Wiskott-Aldrich syndrome like 2 2
MIRT525592 ANKRD49 ankyrin repeat domain 49 2 2
MIRT526047 GMDS GDP-mannose 4,6-dehydratase 2 2
MIRT531124 CLPB ClpB homolog, mitochondrial AAA ATPase chaperonin 2 2
MIRT533604 TNPO1 transportin 1 2 2
MIRT552632 ZBTB41 zinc finger and BTB domain containing 41 2 2
MIRT555505 PNISR PNN interacting serine and arginine rich protein 2 2
MIRT560185 SPRTN SprT-like N-terminal domain 2 2
MIRT571001 REPS1 RALBP1 associated Eps domain containing 1 2 2
MIRT572913 MTMR3 myotubularin related protein 3 2 2
MIRT615263 DPF2 double PHD fingers 2 2 2
MIRT617721 TRAPPC2 trafficking protein particle complex 2 2 4
MIRT617981 ZNF234 zinc finger protein 234 2 4
MIRT618433 MYLK3 myosin light chain kinase 3 2 4
MIRT619670 CYP1A2 cytochrome P450 family 1 subfamily A member 2 2 2
MIRT620534 AVPR1A arginine vasopressin receptor 1A 2 2
MIRT621303 YIPF4 Yip1 domain family member 4 2 2
MIRT625058 ZNF556 zinc finger protein 556 2 2
MIRT627224 ZBTB8B zinc finger and BTB domain containing 8B 2 2
MIRT641086 ZKSCAN2 zinc finger with KRAB and SCAN domains 2 2 2
MIRT645192 POLR3F RNA polymerase III subunit F 2 2
MIRT655546 PADI2 peptidyl arginine deiminase 2 2 2
MIRT663660 ZNF486 zinc finger protein 486 2 4
MIRT664038 RPL27A ribosomal protein L27a 2 2
MIRT664095 ZDHHC24 zinc finger DHHC-type containing 24 2 2
MIRT667034 PDE3A phosphodiesterase 3A 2 2
MIRT693811 SEC31A SEC31 homolog A, COPII coat complex component 2 2
MIRT694235 ZNF749 zinc finger protein 749 2 2
MIRT699244 SLC6A8 solute carrier family 6 member 8 2 2
MIRT702577 JARID2 jumonji and AT-rich interaction domain containing 2 2 2
MIRT702960 HIF1A hypoxia inducible factor 1 alpha subunit 2 2
MIRT703628 FBXL3 F-box and leucine rich repeat protein 3 2 2
MIRT709931 MRPS16 mitochondrial ribosomal protein S16 2 2
MIRT712973 KANSL3 KAT8 regulatory NSL complex subunit 3 2 2
MIRT714884 RAD18 RAD18, E3 ubiquitin protein ligase 2 2
MIRT719140 DPYSL5 dihydropyrimidinase like 5 2 2
MIRT724999 CDC27 cell division cycle 27 2 2
MIRT735830 GREM1 gremlin 1, DAN family BMP antagonist 2 0
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-3128 Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-3128 Tamoxifen 2733525 NSC180973 approved resistant High Breast Cancer cell line (MCF-7)
hsa-mir-3128 Paclitaxel 36314 NSC125973 approved sensitive cell line (A2780)
hsa-mir-3128 Cisplatin 5460033 NSC119875 approved sensitive cell line (A2780)
hsa-mir-3128 Tamoxifen 2733525 NSC180973 approved resistant cell line (MCF7)
hsa-mir-3128 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-3128 Osimertinib 71496458 NSC779217 approved resistant cell line (PC9)
hsa-miR-3128 Osimertinib 71496458 NSC779217 approved resistant cell line (HCC827)
hsa-miR-3128 Cisplatin 5460033 NSC119875 approved sensitive cell line
hsa-miR-3128 Gefitinib 123631 NSC715055 approved resistant cell line (HCC827)
hsa-miR-3128 Prednisone/Azathioprine/Methotrexate/Cyclophosphamide/Mycophenolate mofetil resistant tissue (myasthenia gravis)
hsa-miR-3128 Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-3128 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)

Error report submission